###begin article-title 0
Salivary gland branching morphogenesis: a quantitative systems analysis of the Eda/Edar/NFkappaB paradigm
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 98 102 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda </italic>
###xml 111 115 111 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EDA </italic>
###xml 355 358 355 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda</italic>
###xml 358 361 358 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ta </italic>
###xml 358 361 358 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Ta </italic></sup>
###xml 667 671 663 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda </italic>
###xml 92 97 <span type="species:ncbi:10090">mouse</span>
###xml 105 110 <span type="species:ncbi:9606">human</span>
###xml 376 380 <span type="species:ncbi:10090">mice</span>
Ectodysplasin-A appears to be a critical component of branching morphogenesis. Mutations in mouse Eda or human EDA are associated with absent or hypoplastic sweat glands, sebaceous glands, lacrimal glands, salivary glands (SMGs), mammary glands and/or nipples, and mucous glands of the bronchial, esophageal and colonic mucosa. In this study, we utilized EdaTa (Tabby) mutant mice to investigate how a marked reduction in functional Eda propagates with time through a defined genetic subcircuit and to test the proposition that canonical NFkappaB signaling is sufficient to account for the differential expression of developmentally regulated genes in the context of Eda polymorphism.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 181 184 177 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda</italic>
###xml 184 186 180 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ta</italic>
###xml 184 186 180 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Ta</italic></sup>
###xml 323 327 315 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Edar</italic>
###xml 329 333 321 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf8</italic>
###xml 335 338 327 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shh</italic>
###xml 340 343 332 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egf</italic>
###xml 345 349 337 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tgfa</italic>
###xml 351 355 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egfr</italic>
###xml 490 500 482 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
###xml 212 216 <span type="species:ncbi:10090">mice</span>
The quantitative systems analyses do not support the stated hypothesis. For most NFkappaB-regulated genes, the observed time course of gene expression is nearly unchanged in Tabby (EdaTa) as compared to wildtype mice, as is NFkappaB itself. Importantly, a subset of genes is dramatically differentially expressed in Tabby (Edar, Fgf8, Shh, Egf, Tgfa, Egfr), strongly suggesting the existence of an alternative Eda-mediated transcriptional pathway pivotal for SMG ontogeny. Experimental and in silico investigations have identified C/EBPalpha as a promising candidate.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 605 609 601 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda </italic>
###xml 610 613 606 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EDA</italic>
In Tabby SMGs, upregulation of the Egf/Tgfalpha/Egfr pathway appears to mitigate the potentially severe abnormal phenotype predicted by the downregulation of Fgf8 and Shh. Others have suggested that the buffering of the phenotypic outcome that is coincident with variant Eda signaling could be a common mechanism that permits viable and diverse phenotypes, normal and abnormal. Our results support this proposition. Further, if branching epithelia use variations of a canonical developmental program, our results are likely applicable to understanding the phenotypes of other branching organs affected by Eda (EDA) mutation.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 220 221 220 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 429 430 429 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
Branching morphogenesis is a common mechanism of mammalian development (salivary glands, lungs, mammary glands, pancreas, kidney, etc.), and has been a classic topic of study for generations of developmental biologists [1]. Based on recent findings regarding signal transduction pathways and transcriptional control, it has reasonably been proposed that all branching systems use variations of a canonical developmental program [2]. Ectodysplasin-A, a protein required for epithelial differentiation, appears to be an important constituent of such a program.
###end p 9
###begin p 10
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda </italic>
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EDA </italic>
###xml 76 77 76 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 78 79 78 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 206 207 206 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 208 209 208 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 312 313 312 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 314 315 314 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 429 430 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 431 433 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 487 520 483 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Late Pseudoglandular/Canalicular </italic>
###xml 569 577 565 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 666 668 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 671 680 667 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 956 958 948 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
###xml 38 43 <span type="species:ncbi:9606">human</span>
Ectodysplasin-A (Eda in mouse, EDA in human) is mapped to the X-chromosome [3,4]. Eda is a glycosylated, oligomeric type II membrane protein with three collagenous repeat domains and a TNF homology domain [3-6]. Eda is shed from the cell membrane and binds as a trimer to its trimerized cognate receptor (Edar) [7,8]. Like TNF/TNFR signaling, Eda/Edar signaling is thought to be primarily through the canonical NFkappaB pathway [9-13]. The initial appearance of Eda and Edar proteins in Late Pseudoglandular/Canalicular Stage (E15) submandibular salivary glands (SMGs) in vivo indicate that they participate in late branching morphogenesis and histodifferentiation [14]. In vitro study of the Eda/Edar pathway in embryonic SMG development indicates that this pathway is important for epithelial cell proliferation, lumina formation, and histodifferentiation; exogenous Eda delivered to SMG explants upregulate NFkappaB activation and nuclear localization [14].
###end p 10
###begin p 11
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda </italic>
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EDA </italic>
###xml 222 237 222 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">salivary glands</italic>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 13 18 <span type="species:ncbi:10090">mouse</span>
###xml 30 35 <span type="species:ncbi:9606">human</span>
Mutations in mouse Eda or its human homologue EDA result in hypohydrotic ectodermal dysplasia (HED), a syndrome variably characterized by absent or hypoplastic teeth, hair, sweat glands, sebaceous glands, lacrimal glands, salivary glands, mammary glands and/or nipples, and mucous glands of the bronchial, esophageal and colonic mucosa [14-22].
###end p 11
###begin p 12
###xml 10 13 10 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda</italic>
###xml 13 16 13 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ta </italic>
###xml 13 16 13 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Ta </italic></sup>
###xml 69 70 69 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 71 72 71 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 312 315 312 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda</italic>
###xml 315 318 315 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ta </italic>
###xml 315 318 315 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Ta </italic></sup>
###xml 344 347 344 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda</italic>
###xml 347 350 347 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ta </italic>
###xml 347 350 347 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Ta </italic></sup>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 643 645 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 646 648 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 877 879 877 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
The mouse EdaTa (Tabby) allele is characterized by a ~2 kb deletion [3,4]. Specifically, genomic DNA hybridized with an exon 1 probe shows a deletion including the coding region, and primers for DNA flanking exon 1 fail to amplify in a PCR assay (Jackson Laboratories; ). Importantly, RT-PCR assays of embryonic EdaTa (Tabby) skin reveals that EdaTa transcript levels are about 10-20% of that seen in the wildtype [23,24]. This may reflect the fact that DNA sequences that regulate gene transcription occupy no fixed position relative to coding DNA regions and are often diffuse and widely dispersed, including secondary ("shadow") enhancers [25,26]. Secondary enhancers map far from the target gene and mediate activities overlapping the primary enhancer, accounting for why deletions of well-defined enhancers are sometimes associated with weak or no phenotypic abnormality [25].
###end p 12
###begin p 13
###xml 27 30 27 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda</italic>
###xml 30 33 30 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ta </italic>
###xml 30 33 30 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Ta </italic></sup>
###xml 72 80 72 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 633 637 633 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda </italic>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
In this study, we utilized EdaTa (Tabby) mutant mice to investigate the in vivo relationship between Eda/Edar signaling and progressive (E13-NB) SMG morphogenesis and histodifferentiation. Our investigation reveals that, from the outset (E13), embryonic Tabby SMGs are smaller, exhibit fewer branches, and are developmentally delayed compared to wildtype (WT) glands. By E18, Tabby glands remain smaller with fewer presumptive acini than WT, though both display a similar degree of terminal differentiation (presumptive functional maturation), as evidenced by mucin (MucCAM/Muc10) protein expression. The key question is how altered Eda function is related to abnormal SMG ontogeny.
###end p 13
###begin p 14
Developmental biology has progressed from studying one or two molecules at a time to studying scores of molecules. Such studies require complex experiments and mathematical analyses of their results. While the preferred approach for data analysis has been statistical, its value is limited for mechanistic understanding of signal transduction, mostly because the approach is correlational. To understand how a specific ligand/receptor binding (or lack thereof) produces a change in cell/tissue behavior, one is compelled to utilize a dynamic model of a larger relevant genetic subcircuit. Such dynamic models allow one to test different sets of unbiased assumptions and determine if the predicted behavior matches the actual.
###end p 14
###begin p 15
###xml 337 350 337 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">quantitative </italic>
###xml 655 668 651 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">quantitative </italic>
###xml 732 736 728 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda </italic>
###xml 750 754 746 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda </italic>
###xml 757 760 753 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda</italic>
###xml 760 762 756 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ta</italic>
###xml 760 762 756 758 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Ta</italic></sup>
Thus, the wider goal of the present study was to understand how a marked reduction in functional Eda propagates with time through a defined subcircuit that includes 5 signaling pathways that are both critical for SMG ontogeny and share post-activation downstream targets. More specifically, it was the central objective of our extensive quantitative study to demonstrate the way in which a mechanistic pathway diagram can be programmatically transformed to a corresponding system of ordinary differential equations in order to quantitatively test the proposition that the canonical NFkappaB signaling cascade is sufficient to account for the differential quantitative expression of developmentally-regulated genes in the context of Eda polymorphism (Eda v. EdaTa).
###end p 15
###begin p 16
###xml 87 90 87 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda</italic>
###xml 90 93 90 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ta </italic>
###xml 90 93 90 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Ta </italic></sup>
###xml 147 151 147 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Edar</italic>
###xml 153 157 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shh </italic>
###xml 161 166 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf8 </italic>
###xml 201 204 201 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egf</italic>
###xml 205 213 205 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tgf&#945;</italic>
###xml 214 219 210 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egfr </italic>
###xml 625 629 617 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda </italic>
###xml 630 633 622 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EDA</italic>
Quantitative gene expression analysis and mechanistic kinetic modeling reveal that the EdaTa allele is associated with significantly downregulated Edar, Shh and Fgf8 expression, and vastly upregulated Egf/Tgfalpha/Egfr expression. Further, the results revealed that Eda/Edar signaling is not a major determinant of NFkappaB signaling in normal and mutant Tabby SMG development; rather, TNF is. Moreover, the evidence strongly points to the existence of an important, alternative Eda-initiated transcriptional control pivotal to SMG development. These results are likely to be applicable to other branching organs affected by Eda (EDA) mutation.
###end p 16
###begin title 17
Results
###end title 17
###begin p 18
###xml 15 21 15 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">adult </italic>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
The SMG in the adult Tabby mouse is smaller than the wildtype (WT) gland and is characterized by decreased granular convoluted ducts and acini; there is a significant decrease in mucin protein in the hypoplastic Tabby SMGs compared to WT, but not more than expected given the gland size differences [14,15]. To elucidate the natural history of the pathogenesis, we compared the developmental phenotypes of embryonic (E) days 13-18 Tabby and WT SMGs and relate these to multiple gene expression and putative functional integration of related pathways.
###end p 18
###begin title 19
Progressive pathogenesis of Tabby SMGs
###end title 19
###begin p 20
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 242 254 242 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Initial Bud </italic>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 371 388 371 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Late Initial Bud </italic>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 429 445 429 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pseudoglandular </italic>
###xml 549 551 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 593 610 593 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Late Initial Bud </italic>
###xml 629 631 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 658 674 658 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pseudoglandular </italic>
###xml 696 698 696 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1E</xref>
###xml 784 796 784 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Canalicular </italic>
###xml 858 860 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1F</xref>
###xml 864 866 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1G</xref>
###xml 882 895 882 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Terminal Bud </italic>
###xml 957 959 957 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1H</xref>
###xml 963 965 963 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1I</xref>
###xml 967 969 967 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 973 975 973 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1217 1219 1217 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 1223 1225 1223 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1337 1339 1337 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1K</xref>
###xml 1343 1345 1343 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1L</xref>
###xml 1600 1602 1600 1602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1K</xref>
###xml 1606 1608 1606 1608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1L</xref>
###xml 1614 1616 1614 1616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 1620 1622 1620 1622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 1772 1775 1772 1775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda</italic>
###xml 1775 1778 1775 1778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ta </italic>
###xml 1775 1778 1775 1778 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Ta </italic></sup>
From the outset, embryonic Tabby SMGs are smaller, exhibit fewer branches and are developmentally delayed compared to WT glands (Fig. 1). At E13, the Tabby gland is characterized by a solid epithelial stalk ending in a bulb and achieving the Initial Bud stage (Fig. 1A), whereas the WT gland exhibits deep clefts and the formation of 3-6 epithelial buds (branches) (i.e. Late Initial Bud stage) (Fig. 1B). Moreover, although the Pseudoglandular stage, composed of a network of epithelial branches and terminal buds, is achieved in E14 WT SMGs (Fig. 1D), the Tabby gland has only progressed to Late Initial Bud stage on E14 (Fig. 1C) and does not achieve the Pseudoglandular stage until E15 (Fig. 1E). This developmental delay of approximately 1 day persists in Tabby glands, with the Canalicular stage being seen in E15 WT and E16 Tabby glands (compare Fig. 1F to 1G) and the Early Terminal Bud stage being seen in E16 WT and E17 Tabby glands (compare Fig. 1H to 1I, 2A to 2B). The initial detection of immunolocalized mucin protein in Tabby E17 glands, as well as the similarity of its distribution pattern to E16 WT glands, indicates that Tabby proacinar maturation is also delayed, but not precluded (compare Fig. 2A to 2B). At E18, the Tabby glands remain smaller and exhibit fewer presumptive acini than E18 WT glands (compare Fig. 1K to 1L), a hypoplastic phenotype. Nevertheless, both E18 WT and Tabby SMGs display distinct proacinar lumina bounded by a single layer of cuboidal epithelium and filled with mucin protein, as well as continuity between ductal and proacinar lumina (compare Fig. 1K to 1L, and 2C to 2D). This similarity in E18 Tabby and WT phenotypes indicates that terminal differentiation (presumptive functional maturation) is less affected by the EdaTa mutation.
###end p 20
###begin p 21
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Embryonic Tabby SMGs are developmentally-delayed</bold>
###xml 90 102 90 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Initial Bud </italic>
###xml 309 326 309 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Late Initial Bud </italic>
###xml 337 353 337 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pseudoglandular </italic>
###xml 579 591 579 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Canalicular </italic>
###xml 788 807 788 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Early Terminal Bud </italic>
###xml 1334 1352 1334 1352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Late Terminal Bud </italic>
Embryonic Tabby SMGs are developmentally-delayed. E13 Tabby (TA) SMG (A) has achieved the Initial Bud stage, consisting of a single end bulb. In contrast, E13 wildtype (WT) glands (B) are characterized by cleft formation in the end bud and the formation of a few branches, indicating that it has achieved the Late Initial Bud Stage. The Pseudoglandular stage, composed of a network of epithelial branches and end buds (b), is seen in E14 WT (D) and E15 Tabby (E) SMGs. The presence of ductal lumina (arrows) indicates that the E15 WT (F) and E16 Tabby (G) SMGs have achieved the Canalicular stage. The presence of distinct lumina surrounded by cuboidal epithelia (black arrowhead) in some, but not all, terminal end buds indicates that E16 WT (H) and E17 Tabby (I) SMGs have achieved the Early Terminal Bud stage. By E18, differences in branching morphogenesis and glandular maturation are seen between E18 WT (L) and Tabby (K) glands. Note that the E18 Tabby glands (K) are smaller and exhibits fewer branches than E18 WT glands (L); its branching morphogenesis appears similar to that seen in E17 WT (J) glands. However, the observation of distinct proacinar lumina surrounded by a single layer of cuboidal epithelium (blue arrowhead) and continuity between ductal and proacinar lumina in both E18 Tabby (K) and WT (L) glands (i.e. Late Terminal Bud stage) indicates the similarity in E18 Tabby and WT maturation. Bar: A-D, 40 mum; E-L, 30 mum.
###end p 21
###begin p 22
###xml 0 47 0 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Mucin protein expression in Tabby and WT glands</bold>
###xml 160 179 160 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Early Terminal Bud </italic>
###xml 496 514 496 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Late Terminal Bud </italic>
Mucin protein expression in Tabby and WT glands. Mucin protein is immunolocalized in some, but not all, terminal end buds in E17 Tabby (A) and E16 WT (B) SMGs (Early Terminal Bud stage). By E18, although E18 Tabby SMGs (C) display a notable reduction in total proacini displaying mucin protein compared to E18 WT glands (D), the observation of mucin protein in all proacinar lumen in both E18 Tabby and WT glands indicates similar glandular differentiation and that both glands have achieved the Late Terminal Bud stage. Bar, 20 mum.
###end p 22
###begin title 23
Gene expression
###end title 23
###begin p 24
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 588 590 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 591 593 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 482 487 <span type="species:ncbi:10090">mouse</span>
A key principle of signaling and transcriptional regulation of development is that a wide array of ontogenic effects can emerge from a relatively small number of individual molecular components [27]. This nonlinear process is dependent on the functional integration of information transmitted by diverse pathways. Many such pathways in SMG ontogeny have been identified (see reviews, [28-31]). The putative functional relationships within and between pathways have been modeled for mouse SMGs as the estimative equivalent of a "cafe napkin" sketch, namely a diagrammatic genetic network [28,32].
###end p 24
###begin p 25
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
Mapping genes to their function is called the "genotype-to-phenotype problem," where phenotype is whatever is changed in the organism when a gene's function is altered [33]. Because developmental regulation is both robust and degenerate, it is limiting to simply investigate the average effects of single network genes across samples, large or small [34]. Rather, we are compelled to map genotype to phenotype within the context of the underlying complexity of the networks that regulate cellular functions [33].
###end p 25
###begin p 26
###xml 40 41 40 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 84 85 84 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 87 88 87 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 93 94 93 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
Here we investigated a subcircuit (Fig. 3) that includes 31 probative genes (Tables 1, 2 and 3) in 5 signaling pathways that are both critical to SMG ontogeny and share post-activation downstream targets: Eda, Tnf, Il6, Egf, Fgf [14,28-31,35-42]. This approach has proven very useful, not least because it is experimentally constrained and computationally accessible [43]. Below we present novel emergent properties that would not be otherwise evident.
###end p 26
###begin p 27
###xml 0 201 0 201 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Subcircuit Map: A relational model that postulates how signaling events likely propagate during SMG development; a conceptionally simple subcircuit for subsequent kinetic modeling (see Additional file </bold>
###xml 201 202 201 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 202 277 202 277 <bold xmlns:xlink="http://www.w3.org/1999/xlink">and text) that is experimentally constrained and computationally accessible</bold>
Subcircuit Map: A relational model that postulates how signaling events likely propagate during SMG development; a conceptionally simple subcircuit for subsequent kinetic modeling (see Additional file 1and text) that is experimentally constrained and computationally accessible. This subcircuit is composed of 5 signaling pathways that are both critical to SMG ontogeny and share post-activation downstream targets.
###end p 27
###begin p 28
Relative Gene Expression (R)*: Wildtype (WT)
###end p 28
###begin p 29
* R = Sigmar/n, where gene expression (R) is "normalized" to WT-E15 (r = WT-E16/WT-E15, r = WT-E17/WT-E15, etc.), and n >/= 9. Thus, entries in each cell are mean values (R); values greater or lesser than 1 are significant at P < 0.01 or less.
###end p 29
###begin p 30
Relative Gene Expression (R)*: Tabby (Ta)
###end p 30
###begin p 31
* R = Sigmar/n, where gene expression (R) is "normalized" to WT-E15 (r = Ta-E16/WT-E15, r = Ta-E17/WT-E15, etc.), and n >/= 9. Thus, entries in each cell are mean values (R); values greater or lesser than 1 are significant at P < 0.01 or less.
###end p 31
###begin p 32
Relative Gene Expression: Ta/WT
###end p 32
###begin title 33
WT gene expression
###end title 33
###begin p 34
###xml 289 290 289 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 323 324 323 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 680 682 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 683 685 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 686 688 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 689 691 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 695 697 695 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 698 700 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 701 703 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 704 706 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
We determined the sequential time-dependent changes in the expression of 31 genes from the earliest time of immunodetectable Eda and Edar to newborn by quantitative RT-PCR. The presentation of wildtype (WT) gene expression data for embryonic day 16 (E16) to newborn (NB) is found in Table 1. The relative expression ratio (R) is the mean increase or decrease in gene expression in WT glands compared to a single standard, WT E15 glands, the earliest time of Eda and Edar protein expression. These data are particularly heuristic in our attempt to more fully expand upon what is already known about the control of embryonic SMG branching from prior genotype to phenotype analyses [14,28,30-32,37,38,41,42,44].
###end p 34
###begin p 35
###xml 7 20 7 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Terminal Bud </italic>
###xml 164 169 164 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf8 </italic>
###xml 173 178 173 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgfr2</italic>
###xml 227 232 227 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf10</italic>
###xml 282 295 282 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Terminal Bud </italic>
###xml 408 412 408 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shh </italic>
###xml 450 466 450 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pseudoglandular </italic>
###xml 479 491 479 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Canalicular </italic>
###xml 657 670 653 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Terminal Bud </italic>
###xml 720 723 716 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda</italic>
###xml 725 729 721 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Edar</italic>
###xml 731 738 727 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Edaradd</italic>
###xml 740 743 736 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tnf</italic>
###xml 745 748 741 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il6</italic>
###xml 754 760 750 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nfkb1 </italic>
###xml 956 968 948 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Canalicular </italic>
###xml 981 994 973 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Terminal Bud </italic>
###xml 1021 1025 1013 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egf </italic>
###xml 1072 1081 1064 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tgf&#945; </italic>
###xml 1085 1090 1073 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egfr </italic>
###xml 1148 1167 1136 1155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Early Terminal Bud </italic>
###xml 1259 1262 1247 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egf</italic>
###xml 1264 1272 1252 1256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tgf&#945;</italic>
###xml 1278 1283 1262 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egfr </italic>
Normal Terminal Bud Stage (E16-NB) maturation is critical to subsequent acini and ductal terminal differentiation, postnatally. The steady state gene expression of Fgf8 and Fgfr2, and the more dramatic 20+ fold upregulation of Fgf10, suggests that the Fgf pathways are important to Terminal Bud Stage maturation in the same way they are prior to this stage. This also may be said of the functionally related Shh gene expression. Progression from the Pseudoglandular Stage to the Canalicular Stage, and continued epithelial branching, also includes Eda/Edar, Tnf and Il6 signaling through the canonical NFkappaB pathway. The importance of these pathways for Terminal Bud Stage maturation appears considerably diminished: Eda, Edar, Edaradd, Tnf, Il6, and Nfkb1 gene expression are significantly (P < 0.01) downregulated. Finally, the Egf/Tgfalpha/Egfr pathway regulates the rate of branching and histodifferentiation in preparation for progression from the Canalicular Stage to the Terminal Bud Stage. The steady state of Egf expression and the significant upregulation of Tgfalpha and Egfr suggest the importance of this signaling pathways through Early Terminal Bud Stage (E16); however, beyond this point there is a highly significant (P < 0.01) decline in Egf, Tgfalpha, and Egfr expression, suggesting a greatly diminished role in SMG maturation.
###end p 35
###begin title 36
Tabby gene expression
###end title 36
###begin p 37
###xml 293 294 293 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 299 300 299 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 340 343 340 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda</italic>
###xml 343 346 343 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ta </italic>
###xml 343 346 343 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Ta </italic></sup>
###xml 534 535 534 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 537 538 537 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
To determine if the sequential expression of these important 31 genes differs in Tabby SMGs from that seen in WT SMGs, we also compared Tabby E16 to NB to the same standard (WT E15). The presentation of Tabby SMG gene expression data for E16 to NB, and its comparison to WT is found in Tables 2 and 3. It is readily apparent that embryonic EdaTa SMGs have many highly significant (P < 0.01) gene expression differences as compared to WT. Such differences have always to be viewed in the context of progressive SMG pathogenesis (Figs. 1, 2).
###end p 37
###begin p 38
###xml 7 11 7 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda </italic>
###xml 40 43 40 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda</italic>
###xml 43 46 43 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ta </italic>
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Ta </italic></sup>
###xml 80 99 80 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Early Terminal Bud </italic>
###xml 135 141 135 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nfkb1 </italic>
###xml 179 180 179 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 252 256 252 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tnf </italic>
###xml 329 331 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 337 341 333 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mid </italic>
###xml 344 362 340 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Late Terminal Bud </italic>
###xml 410 416 406 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nfkb1 </italic>
###xml 420 424 416 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tnf </italic>
###xml 442 443 438 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 475 478 471 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egf</italic>
###xml 479 487 475 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tgf&#945;</italic>
###xml 488 493 480 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egfr </italic>
###xml 505 509 497 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egf </italic>
###xml 536 545 528 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tgf&#945; </italic>
###xml 571 576 559 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egfr </italic>
###xml 608 609 596 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 644 656 632 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egf/Tgf&#945;</italic>
###xml 657 662 641 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egfr </italic>
###xml 736 737 720 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 884 888 864 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda </italic>
###xml 957 961 937 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shh </italic>
###xml 965 970 945 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf8 </italic>
###xml 1054 1056 1034 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1057 1059 1037 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1146 1148 1126 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1164 1168 1144 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shh </italic>
###xml 1172 1177 1152 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf8 </italic>
###xml 1314 1317 1294 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda</italic>
###xml 1317 1320 1297 1300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ta </italic>
###xml 1317 1320 1297 1300 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Ta </italic></sup>
Though Eda gene expression in embryonic EdaTa SMGs are 3-19% that of WT, in the Early Terminal Bud Stage there is a 4-fold increase in Nfkb1 gene expression relative to WT (Table 3). This may largely be explained by the concomitant 11-fold increase in Tnf expression, Tnf being a powerful inducer of NFkappaB activation in SMGs [41]. By Mid to Late Terminal Bud stage, this response is replaced by near normal Nfkb1 and Tnf expression (Table 3), and dramatically upregulated Egf/Tgfalpha/Egfr expression: Egf by a relative 10-100 fold; Tgfalpha by a relative 10-30 fold, Egfr by a relative 2.5-5 fold (Table 3). This unexpected upregulation of Egf/Tgfalpha/Egfr message is reflected in the expression of immunodetectable proteins (Fig. 4), with a substantial increase in Egf, Tgfalpha, and Egfr proteins being seen in Tabby SMGs as compared to WT glands. At the same time, diminished Eda expression is associated with significantly (P < 0.01) downregulated Shh and Fgf8 expression, an outcome previously shown to be correlated with severe SMG pathology [38,44]. Shh and Fgf8 are known to positively and reciprocally regulate one another in SMGs [38]. Still, while Shh and Fgf8 expression in WT SMGs is highly correlated (P < 0.01) and the variation of one accounts for nearly all of the variation in the other, in EdaTa SMGs they are not at all correlated (P > 0.90), one accounting for less than 4% of the variation in the other.
###end p 38
###begin p 39
###xml 0 81 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Tabby SMGs exhibit a marked increase in Egf, Tgf&#945; and Egfr protein expression</bold>
Tabby SMGs exhibit a marked increase in Egf, Tgfalpha and Egfr protein expression. A, B. Immunolocalization of Egf protein in E18 WT (A) and Tabby (B) SMGs. C, D. Immunolocalization of Tgfalpha protein in E18 WT (C) and Tabby (D) SMGs. E, F. Immunolocalization of Egfr protein in E18 WT (E) and Tabby (F) SMGs. In WT glands, Egf, Tgfalpha and Egfr proteins are localized to ductal and terminal bud epithelia. In Tabby glands, a substantial increase in immunodetectable Egf, Tgfalpha and Egfr proteins is seen. Bar, 20 mum.
###end p 39
###begin p 40
###xml 35 38 35 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda</italic>
###xml 38 41 38 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ta </italic>
###xml 38 41 38 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Ta </italic></sup>
###xml 104 105 104 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 141 145 141 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shh </italic>
###xml 149 154 149 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf8 </italic>
###xml 306 318 306 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egf/Tgf&#945;</italic>
###xml 319 324 315 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egfr </italic>
###xml 347 348 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 379 380 375 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 490 493 486 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda</italic>
###xml 493 496 489 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ta </italic>
###xml 493 496 489 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Ta </italic></sup>
###xml 572 575 568 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shh</italic>
###xml 577 581 573 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf8</italic>
###xml 583 596 579 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egf, Tgf&#945;</italic>
###xml 598 602 590 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egfr</italic>
In summary, then, the pathology of EdaTa SMGs, relative to the circumscribed signaling subcircuit (Fig. 3), is associated with downregulated Shh and Fgf8 gene expression. Perhaps, as a mark of this subcircuit's robustness, the potential severity of the SMG pathology may be mitigated by vastly upregulated Egf/Tgfalpha/Egfr gene expression (Table 3) and protein expression (Fig. 4). These results naturally raise questions regarding the underlying mechanism that links the loss-of-function EdaTa mutation to the positive and negative regulation of the 5 genes just noted (Shh, Fgf8, Egf, Tgfalpha, Egfr), and the overall putative relationship to NFkappaB-mediated gene regulation.
###end p 40
###begin title 41
Network analysis
###end title 41
###begin p 42
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 593 595 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 698 700 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 1188 1192 1184 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda </italic>
###xml 1206 1210 1202 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda </italic>
###xml 1213 1216 1209 1212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda</italic>
###xml 1216 1218 1212 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ta</italic>
###xml 1216 1218 1212 1214 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Ta</italic></sup>
The expression of an individual gene in a developing organ is not a soliloquy; rather, it acts in a chorus of quantitative functional relations appropriately termed a genetic circuit, network or connections map. It is the task of systems biology to quantitatively define and analyze the parts (subcircuits) of the whole, the goal being to put it all together in the future [45-49]. To do this, two effective strategies have emerged. One seeks to infer biologic pathways from large data sets and increasingly powerful software tools for managing and searching literature and pathway databases [50]. The second seeks to construct and test increasingly complex mechanistic models of biologic systems [51]. Here we have combined these strategies to determine the way in which a mechanistic pathway diagram (derived from our prior studies, the literature, and pathway databases) can be programmatically transformed to a corresponding system of ordinary differential equations in order to quantitatively test the proposition that the canonical NFkappaB signaling cascade is sufficient to account for the differential quantitative expression of developmentally regulated genes in the context of Eda polymorphism (Eda v. EdaTa).
###end p 42
###begin p 43
###xml 162 163 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 165 166 165 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 171 172 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 179 180 179 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 795 796 795 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 964 965 964 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 983 984 983 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 1002 1003 1002 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 1021 1022 1021 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
Pathway and literature databases were mined for processes that interrelate a quantitatively measured panel of genes which are critical to SMG development (Tables 1, 2 and 3; Fig. 3). Mined processes were assembled into a mechanistic kinetic framework and the model was tested for consistency with the WT and Tabby quantitative RT-PCR derived expression data. The resulting best-fit mechanistic system diagram contains 138 states (a state being a molecule or a complex in a physical place) in 5 cellular locations (nucleus, cytoplasm, secretory pathway, plasma membrane and extracellular space), and 217 processes (transport, chemical transformation or binding). The system diagram is too large to be displayed legibly on a journal page, but is provided as a scalable PDF file in Additional file 1, along with access to all the equations and parameters for both WT and Tabby data sets, as well as the fits of the quantitative experimental data (see Additional file 2; Additional file 3; Additional file 4; Additional file 5).
###end p 43
###begin p 44
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 228 233 <span type="species:ncbi:4932">yeast</span>
###xml 238 245 <span type="species:ncbi:562">E. coli</span>
Previous systems analyses have utilized computational methods that allow ready deduction of genetic network connectivity and functional properties solely from gene expression data, temporal or not [52]. Still, recent studies in yeast and E. coli compel the caveat that the ratios of protein levels between mutant and WT may not have a one-to-one correlation with those of the corresponding mRNAs [53,54]. Further, since the mechanistic diagram inevitably includes a large number of proteins as well as expressed mRNAs, we concede at the outset that gene expression data alone are not sufficient to allow highly detailed parameter identification of the downstream protein networks.
###end p 44
###begin p 45
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
Fortunately, the kinetic characteristics of signaling circuits provide general constraints that support quantitative analysis of gene expression data in isolation. First, it is generally agreed that protein transport from the site of synthesis in the ER to the cell surface requires no more than 30 minutes [55]. Second, it is widely acknowledged that signaling pathways require on the order of only two minutes to convey information from the plasma membrane to the nucleus. Since the developmental time courses we analyze include transients on a time scale of 4 to 5 days, we adopted the working hypothesis that signal transduction events (mediated by protein transport in the secretory pathway, receptor binding, and binding to response elements) are fast relative to the dynamics of transcription, mRNA turnover, translation and protein turnover. This simplification allows a full mechanistic test of a complex hypothetical model even in the absence of experimental protein kinetic data on secreted cytokines and growth factors, activated enzymes, and transcription factors (see Methods).
###end p 45
###begin p 46
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda </italic>
###xml 41 47 41 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">major </italic>
###xml 164 165 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 187 188 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 404 408 396 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda </italic>
###xml 599 600 591 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 725 729 713 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Edar</italic>
###xml 731 735 719 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf8</italic>
###xml 737 740 725 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shh</italic>
###xml 742 745 730 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egf</italic>
###xml 807 808 791 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 878 879 862 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 901 902 885 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 933 937 917 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda </italic>
###xml 1117 1121 1097 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Edar</italic>
###xml 1123 1127 1103 1107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf8</italic>
###xml 1129 1132 1109 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shh</italic>
###xml 1134 1137 1114 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egf</italic>
It is readily apparent that Eda is not a major determinant of NFkappaB signaling. This conclusion is inescapable given the large number of genes in the model (Fig. 3; see Additional file 1) whose transcription is reported to be significantly regulated by canonical NFkappaB. Given our working assumption that all differences between WT and Tabby developmental mRNA profiles are secondary to differential Eda expression, it must follow that if Eda is the dominant determinant of Eda/Edar signaling, then the Tabby state of many-fold less Eda must propagate in this kinetic model (see Additional file 1) into much reduced expression of genes whose transcription is significantly regulated by NFkappaB. To the contrary, only 4 (Edar, Fgf8, Shh, Egf) of the 17 genes thought to be NFkappaB response genes (Fig. 3) have dramatically different time courses in WT and Tabby SMGs (Fig. 5; see Additional file 2). This strongly suggests that Eda is not a major determinant of NFkappaB activation in SMG branching morphogenesis, and presages the existence of an additional Eda-initiated transcriptional control of the 4 genes: Edar, Fgf8, Shh, Egf.
###end p 46
###begin p 47
###xml 96 101 92 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Edar </italic>
###xml 109 114 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf8 </italic>
###xml 122 126 118 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shh </italic>
###xml 134 138 130 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egf </italic>
###xml 0 144 0 140 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Time course fits of the WT and Tabby experimental data for a subset of NF&#954;B response genes: <italic>Edar </italic>(a, b); <italic>Fgf8 </italic>(c, d); <italic>Shh </italic>(e, f), <italic>Egf </italic>(g, h)</bold>
###xml 596 600 <span type="species:ncbi:10090">mice</span>
Time course fits of the WT and Tabby experimental data for a subset of NFkappaB response genes: Edar (a, b); Fgf8 (c, d); Shh (e, f), Egf (g, h). The vertical axis is the relative abundance of mRNA, as presented in Tables 1 and 2. The lines labeled "WT data" are the quantitative RT-PCR derived mRNA data in wildtype SMGs; the lines labeled "WT model" are model simulated expected mRNA expression for wildtype SMGs. The lines labeled "TA data" are the quantitatively RT-PCR derived mRNA data in Tabby SMGs; the lines labeled "TA model" are model simulated expected mRNA expression for Tabby SMGs mice.
###end p 47
###begin p 48
###xml 45 51 45 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nfkb1 </italic>
###xml 118 119 118 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 213 214 213 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 219 220 219 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 223 229 223 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nfkb1 </italic>
###xml 304 305 304 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 366 367 366 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 385 386 385 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 404 405 404 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 423 424 423 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 590 596 586 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nfkb1 </italic>
###xml 873 875 865 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 930 934 922 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink">not </italic>
###xml 1001 1005 993 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">and </italic>
###xml 1037 1038 1029 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1056 1057 1048 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 1075 1076 1067 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 1094 1095 1086 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
Concomitantly, it is informative to consider Nfkb1 gene expression itself. The mechanistic model (see Additional file 1) accounts for the observed significant, but transient, decrease in WT and Tabby SMGs (Tables 1 and 2); Nfkb1 expression has essentially the same time course in WT and Tabby SMGs (Fig. 6). Interestingly, the mechanistic model (see Additional file 1; Additional file 3; Additional file 4; Additional file 5) demonstrates that the resulting decrease in protein synthesis is largely buffered by the pre-existing cytoplasmic pool of NFkappaB1, and thus the downregulation of Nfkb1 has little effect on the propagation of Eda, Fgf10, and Tnf induced signals to the nucleus. Further, since prior SMG studies demonstrated that a significant portion of the activation and nuclear translocation of NFkappaB can be accounted for by the variation in Tnf signaling [32], we tested and corroborated the hypothesis that Tnf, not Eda, is the dominant controller of IKK activation in developing WT and Tabby SMGs (see Additional file 1; Additional file 3; Additional file 4; Additional file 5).
###end p 48
###begin p 49
###xml 59 65 59 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nfkb1 </italic>
###xml 0 80 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Time course fits of the WT and Tabby experimental data for <italic>Nfkb1 </italic>gene expression</bold>
###xml 530 534 <span type="species:ncbi:10090">mice</span>
Time course fits of the WT and Tabby experimental data for Nfkb1 gene expression. The vertical axis is the relative abundance of mRNA, as presented in Tables 1 and 2. The lines labeled "WT data" are the quantitative RT-PCR derived mRNA data in wildtype SMGs; the lines labeled "WT model" are model simulated expected mRNA expression for wildtype SMGs. The lines labeled "TA data" are the quantitative RT-PCR derived mRNA data in Tabby SMGs; the lines labeled "TA model" are model simulated expected mRNA expression for Tabby SMGs mice.
###end p 49
###begin p 50
###xml 49 58 49 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 278 280 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 460 462 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 463 465 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 566 568 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
To address this question further, we employed an in vitro loss-of-function strategy to determine if loss of canonical NFkappaB function abrogates Eda-enhanced SMG branching and maturation. We utilized SN50, a cell permeable inhibitor of NFkappaB translocation into the nucleus [56], at a concentration (100 mug/ml) previously shown to entirely preclude Tnf- and Eda-induced NFkappaB nuclear translocation and to significantly inhibit embryonic SMG branching ([32,57], unpublished). To enhance SMG branching, we used 250 ng/ml Eda-A1 in a manner previously reported [14]. Thus, E14 explants were cultured for 7 days (E14 + 7) in the presence of 250 ng/ml Eda-A1, 100 mug/ml SN50, or 250 ng/ml Eda-A1 + 100 mug/ml SN50; controls consisted of E14 explants cultured in control medium alone.
###end p 50
###begin p 51
###xml 139 144 139 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7C, D</xref>
###xml 148 153 148 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A, B</xref>
###xml 444 449 444 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7E, F</xref>
###xml 453 458 453 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A, B</xref>
###xml 662 667 662 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7E, F</xref>
###xml 671 676 671 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7C, D</xref>
###xml 774 787 770 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sine qua non </italic>
Eda supplementation induces a substantial increase (Jaskoll et al., 2003; data not shown) and SN50 induces a marked decrease (compare Fig. 7C, D to 7A, B) in embryonic SMG branching morphogenesis and terminal differentiation, as indicated by mucin protein expression. The presence of exogenous Eda supplementation in SN50-treated explants "rescued" the SN50-induced abnormal phenotype and restored it toward that seen in controls (compare Fig. 7E, F to 7A, B). Note that Eda + SN50-treated glands exhibit a marked increase in epithelial terminal buds, lumina formation, and immunodetectable mucin protein compared to glands treated with SN50 alone (compare Fig. 7E, F to 7C, D). Taken together, our results would indicate that a fully functional NFkappaB pathway is not the sine qua non for Eda signaling, and that Eda signaling likely uses additional, more critical and yet unidentified, pathway(s).
###end p 51
###begin p 52
###xml 0 52 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">NF&#954;B function is not essential for Eda signaling</bold>
NFkappaB function is not essential for Eda signaling. A, B. E14 + 7 control SMG. C, D. E14 + 7 SMGs cultured in 100 mug/ml SN50. E, F. E14 + 7 SMGs cultured in 250 ng/ml Eda-A1 + 100 mug/ml SN50. A, C, E. Histological analysis. B, D, F. Immunolocalization of mucin protein. SN50 treatment (C, D) induces an abnormal glandular phenotype, characterized by a notable decrease in epithelial ducts and buds (b), dilated ductal lumina (*) and a marked decrease in immunodetectable mucin protein compared to controls (compare C, D to A, B). EDA treatment of SN50-treated explants (E, F) rescues the SN50-induced abnormal phenotype and restores it toward that seen in controls (compare E, F to A, B). The Eda + SN50-treated glands exhibit a marked increase in epithelial ducts and buds, more normally-appearing lumina, and a marked increase in immunodetectable mucin protein compared to glands treated with SN50 alone (compare E, F to C, D). Bar: A, C, E- 40 mum; B, D, F- 25 mum.
###end p 52
###begin p 53
###xml 67 68 67 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 169 171 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 393 395 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 530 534 526 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">all </italic>
###xml 701 703 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7E</xref>
These conclusions were supported by gene expression analysis (Fig. 8). SN50-treated explants show a decline in gene expression of 9 of 10 NFkappaB1 response genes (Fig. 8A). An optimized (neural network) gene expression model was derived, resulting in a molecular signature that was able to distinguish between SN50-treated and Eda-treated explants with 100% sensitivity and specificity (Fig. 8B). More importantly, when we used the derived model to classify the gene expression data of Eda + SN50-treated explants, we found that all Eda + SN50-treated explants (n = 9) were classified as "Eda-treated" and none were classified as "SN50-treated." This is consistent with the histologic "rescue" (Fig. 7E) and again suggests Eda signaling uses pathways in addition to NFkappaB.
###end p 53
###begin p 54
###xml 12 21 12 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 0 132 0 128 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Comparative <italic>in vitro </italic>gene expression between E14 + 7 SMG explants with NF&#954;B loss-of-function and those with Eda gain-of-function</bold>
Comparative in vitro gene expression between E14 + 7 SMG explants with NFkappaB loss-of-function and those with Eda gain-of-function. A. Quantitative RT-PCR derived relative gene expression in SN50-treated (+SN50) and Eda-treated (+Eda) explants compared to controls. B. Probabilistic Neural Network (PNN) analysis was used to determine the contribution of each gene to the discrimination between SN50-treated and Eda-treated phenotypes. PNN analyses identify the relative importance (0-1, with 0 being of no relative importance and 1 being relatively most important) of specific gene expression changes that distinguish between SN50-treated and Eda-treated phenotypes.
###end p 54
###begin p 55
###xml 44 45 44 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 47 48 47 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 53 54 53 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 219 222 219 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egf</italic>
###xml 224 232 224 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tgf&#945;</italic>
###xml 234 237 230 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shh</italic>
###xml 239 243 235 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf8</italic>
###xml 245 249 241 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Edar</italic>
###xml 251 256 247 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egfr </italic>
###xml 263 264 259 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 266 267 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 313 314 309 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 332 333 328 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 351 352 347 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 370 371 366 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 469 473 465 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shh </italic>
###xml 477 481 473 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf8</italic>
###xml 717 721 709 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egf </italic>
###xml 725 729 717 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Edar</italic>
###xml 906 915 894 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tgf&#945; </italic>
###xml 919 923 903 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egfr</italic>
Within our gene expression datasets (Tables 1, 2 and 3), there are four growth factors and two growth factor receptors whose quantitative expression time courses are dramatically different in Tabby SMGs relative to WT: Egf, Tgfalpha, Shh, Fgf8, Edar, Egfr (Figs. 5, 9). The mechanistic model (see Additional file 1; Additional file 3; Additional file 4; Additional file 5) is internally consistent with some of these but totally incapable of accounting for others. For Shh and Fgf8, the small differences in nuclear NFkappaB1 caused by differential Tnf signaling plus the purported feedback of these genes on one another are sufficient to explain the temporal phenotypes of Tabby gene expression reasonably well. For Egf and Edar, the necessity for a second (non-NFkappaB) Eda-induced transcriptional regulator is clearly indicated by the discrepancies between model solution and mRNA expression data. For Tgfalpha and Egfr, the model solutions are internally consistent but the link to Eda remains unknown. That is, the model can correctly propagate the different temporal phenotypes of WT and Tabby gene expression, but the model cannot explain the causal chain of events that links these genes to Eda. These discrepancies and missing links compelled us to consider an alternative mechanistic explanation and refine the model.
###end p 55
###begin p 56
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tgfa </italic>
###xml 75 80 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egfr </italic>
###xml 0 102 0 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Time course fits of the WT and Tabby experimental data for <italic>Tgfa </italic>(a, b) and <italic>Egfr </italic>(c, d) gene expression</bold>
###xml 552 556 <span type="species:ncbi:10090">mice</span>
Time course fits of the WT and Tabby experimental data for Tgfa (a, b) and Egfr (c, d) gene expression. The vertical axis is the relative abundance of mRNA, as presented in Tables 1 and 2. The lines labeled "WT data" are the quantitative RT-PCR derived mRNA data in wildtype SMGs; the lines labeled "WT model" are model simulated expected mRNA expression for wildtype SMGs. The lines labeled "TA data" are the quantitative RT-PCR derived mRNA data in Tabby SMGs; the lines labeled "TA model" are model simulated expected mRNA expression for Tabby SMGs mice.
###end p 56
###begin p 57
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
###xml 809 813 809 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Edar</italic>
###xml 815 819 815 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shh </italic>
###xml 823 828 823 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf8 </italic>
###xml 879 892 879 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egf, Tgf&#945;</italic>
###xml 898 903 894 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egfr </italic>
###xml 934 936 930 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
###xml 1000 1009 996 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico</italic>
###xml 1011 1019 1007 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1023 1032 1019 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
To wit, we hypothesized and tested the alternative model that a second pathway is activated by Eda/Edar signaling, and that its activated transcription factor ("TFx") regulates the six differently expressed genes in unique ways (Fig. 10). With this addition, all six quantitative gene expression time courses are now internally consistent with and accounted for by the mechanistic model. Further, it is possible to deduce whether the added transcriptional regulation is positive or negative. If gene expression is decreased in Tabby SMGs, TFx must be a positive regulator of that gene. Conversely, if gene expression is increased in Tabby SMGs, then TFx must be a negative regulator of transcription. Examination of the quantitative gene expression data (Tables 1 and 2) reveals that there are three of each: Edar, Shh and Fgf8 are positively regulated by the Eda-activated TFx; Egf, Tgfalpha, and Egfr are negatively regulated (Fig. 10). The identity of TFx is presently uncertain. However, further in silico, in vivo and in vitro investigations suggest a promising candidate.
###end p 57
###begin p 58
###xml 0 107 0 107 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Alternative kinetic model incorporating unknown transcription factor (TFx) activation by Eda/Edar signaling</bold>
Alternative kinetic model incorporating unknown transcription factor (TFx) activation by Eda/Edar signaling. This model is a diagram of the alternative hypothesis that is more consistent with the quantitative mRNA data for Eda/Edar signaling than the hypothesis that NFkappaB1 serves as the main signaling pathway mediating Eda/Edar signaling. Black arrows represent processes (chemical reactions, transport, or binding). Rectangles represent states. A state is a molecule or complex in a physiologic place. The states are color coded as follows: Yellow is the unknown transcription factor TFx and its upstream activation signaling pathway; purple are the mRNA's; green are the promoters that are upregulated by TFx; red are the promoters that are downregulated by TFx. Places are represented by the background ivory or mauve bands of color and are labeled at the bottom of the diagram. Green and red dashed lines represent, respectively, positive or negative regulation of process by states. Processes with only starts or ends cross the boundary of the modeled system. This diagram was produced by ProcessDB software .
###end p 58
###begin title 59
Searching for TFx
###end title 59
###begin p 60
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 122 125 122 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 744 746 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 799 809 791 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
###xml 843 845 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
###xml 893 899 885 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cebpa </italic>
###xml 1121 1124 1109 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11B</xref>
###xml 1128 1131 1116 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11A</xref>
###xml 1332 1335 1312 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11D</xref>
###xml 1339 1342 1319 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11C</xref>
###xml 1373 1382 1353 1362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1481 1489 1457 1465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1493 1502 1469 1478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
Regulatory trans-acting transcription factors (TF) activate or repress transcription by physical interaction with genomic cis-regulating DNA elements that may be found in promoters or at some distance from the target gene's start site(s) (see review, [58]). Putative interactions between TFs and their target DNA sequences can be identified by web-based tools for searching TF binding sites in DNA sequences. Using AliBaba 2.1, TRANSFAC 12.1, MATCH 11.2, and P-MATCH 1.0 (see Methods), we determined that the most probable identity of TFx is CCAAT/enhancer binding protein alpha (C/EBPalpha). C/EBPalpha is part of a family of leucine zipper proteins that control the differentiation of many cell types, as well as regulate cell proliferation [59]. Gene and protein analyses are consistent with our in silico result and model prediction (Fig. 10). Quantitative RT-PCR reveals a 60% decline in Cebpa message in Tabby glands relative to WT at E16, and a 25% decline at E17. In addition, there is a dramatic reduction in activated, nuclear-localized C/EBPalpha protein in Tabby SMGs relative to WT SMGs at E17 (compare Fig. 11B to 11A). To further delineate the relationship between Eda/Edar signaling and C/EBPalpha, we compared the spatial distribution of C/EBPalpha protein in Eda-treated and control E14 + 7 explants (compare Fig. 11D to 11C). Enhanced Eda/Edar signaling in vitro induces a notable increase in activated, nuclear-localized C/EBPalpha protein. Taken together, our in vivo and in vitro data suggest that C/EBPalpha is an Eda responsive gene, thus a promising TFx candidate.
###end p 60
###begin p 61
###xml 61 69 57 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 0 89 0 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C/EBP&#945; protein immunolocalization in WT and Tabby glands <italic>in vivo </italic>and in cultured SMGs</bold>
###xml 97 105 93 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo </italic>
C/EBPalpha protein immunolocalization in WT and Tabby glands in vivo and in cultured SMGs. A, B. In vivo distribution of C/EBPalpha protein in E17 WT (A) and Tabby (B) SMGs. C/EBPalpha protein is primarily localized in nuclei (arrowheads) of epithelial cells surrounding ductal and terminal bud lumina in E17 SMGs. There is a notable decrease in nuclear-localized C/EBPalpha protein, as well as a marked increase in DAPI-stained nuclei, in Tabby glands (B) compared to WT glands (A). C, D. C/EBPalpha protein immunolocalization in cultured control (C) and Eda-A1-treated (D) explants. Eda treatment (D) induces a marked increase in immunodectable and nuclear-localized (arrowheads) C/EBPalpha protein compared to controls (compare D to C). Note that in controls glands (C), C/EBPalpha protein is found in the cytoplasm whereas the nuclei are labeled with DAPI alone (arrows). Inserts C, D. Higher magnifications showing cytoplasmic-localized C/EBPalpha protein in controls (C) and nuclear-localized C/EBPalpha protein in Eda-treated (D) SMGs. Bar, A-B: 20 mum, C-D: 30 mum; C-D inserts: 10 mum.
###end p 61
###begin p 62
###xml 162 164 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 165 167 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 180 183 176 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 289 291 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 331 334 327 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shh</italic>
###xml 336 340 332 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf8</italic>
###xml 342 346 338 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Edar</italic>
###xml 348 351 344 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egf</italic>
###xml 412 414 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
###xml 481 483 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 592 596 572 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egf </italic>
###xml 746 748 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 848 851 820 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shh</italic>
###xml 853 857 825 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf8</italic>
###xml 859 863 831 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Edar</italic>
###xml 869 872 841 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egf</italic>
###xml 436 441 <span type="species:ncbi:9606">human</span>
###xml 828 834 <span type="species:ncbi:10090">murine</span>
The ability of C/EBPalpha to regulate differentiation and proliferation in a context-specific manner often depends on the presence of specific collaborating TFs [59,60]. Composite cis-regulating elements are combinations of two or more TF binding sites with synergistic regulatory action [61]. Our model predicts that 4 key genes (Shh, Fgf8, Edar, Egf) would contain NFkappaB/C/EBPalpha composite elements (Fig. 10). Scanning all known human 5'-flanking sequences, Shelest et al. [61] found that the most abundant composite elements were of the NFkappaB/C/EBPalpha type, including one in the Egf sequence and another in the sequence of a TNF receptor superfamily member. Applying the model for composite elements of the NFkappaB/C/EBPalpha type [61], we determined that such putative composite elements were also present in the murine sequences of Shh, Fgf8, Edar, and Egf.
###end p 62
###begin p 63
###xml 69 71 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
That C/EBPalpha is the identity of postulated TFx in the model (Fig. 10) is far from certain. Still, it is an informed hypothesis which can be tested further with protein-protein and protein-DNA interaction assays of high sensitivity and specificity, among other strategies.
###end p 63
###begin title 64
Discussion
###end title 64
###begin p 65
###xml 776 778 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 254 257 <span type="species:ncbi:9606">men</span>
###xml 420 423 <span type="species:ncbi:9606">men</span>
In 1875, Charles Darwin presented a meticulous description of what we now know as X-linked Hypohydrotic Ectodermal Dysplasia (XLHED): "I may give an analogous case, communicated to me by Mr. W. Wedderburn of a Hindoo [sic] family in Scinde, in which ten men, in the course of four generations, were furnished, in both jaws taken together, with only four small and weak incisor teeth and with eight posterior molars. The men thus affected have very little hair on their body, and become bald early in life. They also suffer much during hot weather from excessive dryness of their skin. It is remarkable that no instance has occurred of a daughter being affected...though they transmit the tendency to their sons; and no case has occurred of a son transmitting it to his sons" [62].
###end p 65
###begin p 66
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 243 260 243 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans </italic>
###xml 279 282 279 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda</italic>
###xml 282 284 282 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ta</italic>
###xml 282 284 282 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Ta</italic></sup>
###xml 388 391 388 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda</italic>
###xml 391 394 391 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ta </italic>
###xml 391 394 391 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Ta </italic></sup>
###xml 534 536 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 537 539 537 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 559 568 559 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 732 734 728 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 765 768 761 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda</italic>
###xml 768 771 764 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ta </italic>
###xml 768 771 764 767 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Ta </italic></sup>
###xml 827 828 823 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 829 830 825 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 994 996 990 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 997 999 993 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1000 1002 996 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1003 1005 999 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 213 221 <span type="species:ncbi:9606">patients</span>
###xml 243 259 <span type="species:ncbi:5476">Candida albicans</span>
###xml 291 296 <span type="species:ncbi:10090">mouse</span>
###xml 310 315 <span type="species:ncbi:9606">human</span>
###xml 338 343 <span type="species:ncbi:9606">human</span>
###xml 948 953 <span type="species:ncbi:10090">mouse</span>
###xml 958 963 <span type="species:ncbi:9606">human</span>
Patients with X-linked HED have since been shown to also have SMG hypoplasia and variably reduced salivary secretion [19-21,63]. The reduced saliva flow results in dryness of the oral mucosa and predisposes XLHED patients to dental caries and Candida albicans infections. Tabby (EdaTa) is a mouse homologue of human XLHED, a model of the human syndrome that displays near identity. Adult EdaTa SMGs are hypoplastic with decreased granular convoluted ducts and acini, and there is a notable decrease in immunodetectable mucin protein [14,15]. Prior studies of in vitro SMG ontogeny suggested that Eda/Edar signaling effects epithelial cell proliferation, lumen formation, and histodifferentiation via the canonical NFkappaB pathway [14]. Of great interest, although EdaTa results in a severely diminished functional Eda ligand [3,4], hemizygosity (males) and homozygosity (females) for the mutant allele result in variable (mild to moderate) adult (mouse and human) SMG hypoplasia, not aplasia [14,19-21,63].
###end p 66
###begin p 67
###xml 28 40 28 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mus musculus</italic>
###xml 42 55 42 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">homo sapiens </italic>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 758 760 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 28 40 <span type="species:ncbi:10090">mus musculus</span>
###xml 42 54 <span type="species:ncbi:9606">homo sapiens</span>
The reproductive success of mus musculus, homo sapiens and other thriving organisms is in no small measure due to their robustness against perturbations, including gene mutation. This robustness may be seen at all levels of biologic organization from gene expression to terminal organ differentiation and function. What might be the basis of "robustian" rescue (partial or full) from perturbations? Several recent lines of experimental evidence suggest that cells, and their genetic regulatory networks, are dynamically critical [64-68]. Such critical dynamical systems, poised between dynamical order and chaos, maximize the correlated behavior of variables in systems of many variables and maximize the diversity of what they can do as they become larger [69]. In the present study, we sought to detect and measure the degree of SMG developmental robustness, and to elucidate its underlying genetic mechanism.
###end p 67
###begin p 68
###xml 27 35 27 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 47 50 47 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda</italic>
###xml 50 52 50 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ta</italic>
###xml 50 52 50 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Ta</italic></sup>
###xml 84 85 84 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 87 88 87 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 100 112 100 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Initial Bud </italic>
###xml 297 336 297 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Late Pseudoglandular/Early Canalicular </italic>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 409 427 409 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Late Terminal Bud </italic>
We began by clarifying the in vivo ontogeny of EdaTaassociated SMG pathology (Figs. 1, 2). From the Initial Bud stage (E13) on, Tabby SMGs are smaller, exhibit fewer branches and are developmentally delayed compared to WT glands. This is consistent with the findings that in immunodetected in the Late Pseudoglandular/Early Canalicular stage (~E15) [14]. Of note, though Eda protein is detectable through the Late Terminal Bud Stage (E18-19), comparison of E18 Tabby and WT proacinar phenotypes indicates that terminal differentiation (presumptive functional maturation) is less affected by Eda loss-of-function.
###end p 68
###begin p 69
###xml 10 19 10 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 26 28 26 28 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 298 306 286 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 371 373 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 390 393 378 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p50</italic>
###xml 393 397 381 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 583 585 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 586 588 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
###xml 541 546 <span type="species:ncbi:10090">mouse</span>
Our prior in vitro study [14] clearly showed that control glands express very little activated NFkappaB, but enhanced Eda/Edar signaling induces a very significant increase in activated NFkappaB. What we did not show was whether or not canonical NFkappaB activation was necessary or sufficient for in vivo Eda/Edar signaling. We had our doubts because Baltimore's group [70] had shown that p50-/- mice have normal development, except for some postnatal (6 weeks) defects in immune responses. Further, we investigated the IkBalpha transgenic mouse created by Schmidt-Ullrich's group [12,71] and the SMGs are normal (unpublished).
###end p 69
###begin p 70
###xml 691 693 691 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 811 813 811 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 814 816 814 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 817 819 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 881 883 881 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 884 886 884 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 887 889 887 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 890 892 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 893 895 893 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B76">76</xref>
Branching morphogenesis is not a simple dichotomous trait, one we mark present or absent. Rather, it is a complex quantitative trait. Defining the interactions that occur among the genes that underlie the process of branching is essential to understanding its variability. When a gene that is critical to this developmental process mutates, the differentiating cells reprogram transcription via a cognate genetic circuit, ultimately altering the expression of the many genes beyond the mutated one. As such, the phenotype of a given genotype cannot be simply predicted by the sum of its component single-locus effects, but must take account of the almost certain epistasis in gene function [72]. The most efficient way of doing this is by systems analysis, correlation modeling for hypothesis generation (e.g. [32,73,74]) and kinetic (mechanistic) modeling for hypothesis testing [46,48,49,75,76].
###end p 70
###begin p 71
###xml 44 47 44 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda</italic>
###xml 47 49 47 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ta</italic>
###xml 47 49 47 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Ta</italic></sup>
###xml 115 119 115 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shh </italic>
###xml 123 128 123 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf8 </italic>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 315 317 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 326 327 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 329 330 329 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 399 402 399 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egf</italic>
###xml 403 411 403 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tgf&#945;</italic>
###xml 412 417 408 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egfr </italic>
###xml 429 430 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 450 451 446 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 522 523 518 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 545 546 541 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 662 664 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 791 793 783 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 991 1000 979 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1130 1131 1114 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 1133 1134 1117 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 1198 1200 1182 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
###xml 1280 1287 1260 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
The molecular pathology of embryonic Tabby (EdaTa) SMGs is characterized by significantly (P < 0.01) downregulated Shh and Fgf8 gene expression, on the order of 50-75% less than WT. Typically, this would be expected to be associated with a severely hypoplastic to aplastic gland [38,44], but this is not the case ([14]; Figs. 1, 2). One obvious explanation for this is the many-fold upregulation of Egf/Tgfalpha/Egfr gene (Table 3) and protein (Fig. 4) expression. This dramatic robustness of the studied subcircuit (Fig. 3; see Additional file 1) is largely due to degeneracy, namely the ready availability of multiple parallel pathways at a key "choice point [34]. Mechanistic modeling reveals that the primary linchpin of this degeneracy is not canonical NFkappaB as previously supposed [14]; rather, we provide extensive quantitative evidence that the Eda/Edar/NFkappaB cascade plays a minor role, apparently neither necessary nor sufficient for SMG development. We confirm this with an in vitro strategy that demonstrates that loss of NFkappaB function does not abrogate Eda-enhanced SMG branching and differentiation (Figs. 7, 8). These outcomes add support to the suggestion by Pispa et al [77] of an important NFkappaB-independent pathway downstream of Eda/Edar signaling in vivo.
###end p 71
###begin p 72
###xml 192 195 188 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shh</italic>
###xml 197 201 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf8</italic>
###xml 203 206 199 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egf</italic>
###xml 208 216 204 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tgf&#945;</italic>
###xml 218 223 210 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egfr </italic>
###xml 229 231 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
###xml 246 256 238 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
###xml 260 268 252 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 386 388 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 583 585 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B78">78</xref>
###xml 661 663 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B79">79</xref>
The most parsimonious alternative explanation is a second Eda-activated transcription factor ("TFx") that regulates, alone or complexed with NFkappaB, the expression of all five target genes: Shh, Fgf8, Egf, Tgfalpha, Egfr (Fig. 10). Our initial in silico and in vivo investigations suggest that the identity of TFx is C/EBPalpha, a regulator of cell proliferation and differentiation [59]. There are likely other, as yet unknown, TFs in the Eda/Edar pathway. Unmasking TFx with certainty, and delineating its participation in transcription factor complexes, could prove formidable [78]; delineating the stochastic variation in cognate gene expression more so [79].
###end p 72
###begin p 73
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B80">80</xref>
###xml 463 467 463 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda </italic>
###xml 468 471 468 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EDA</italic>
###xml 38 43 <span type="species:ncbi:9606">human</span>
The variable phenotypic expression of human hypohydrotic ectodermal dysplasia is considerable ([22,80]; Melnick unpublished). This is particularly so for glandular phenotypes (salivary, sweat, sebaceous, lacrimal, mammary, and mucous). If branching epithelia use variations of a canonical developmental program, the experimental results presented here should be applicable to understanding the variable phenotypic expression of other branching organs affected by Eda (EDA) mutation.
###end p 73
###begin title 74
Conclusion
###end title 74
###begin p 75
###xml 21 30 21 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 159 161 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 176 184 172 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 466 467 458 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 498 499 486 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 594 598 582 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Edar</italic>
###xml 600 604 588 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf8</italic>
###xml 606 609 594 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shh</italic>
###xml 611 620 599 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egf, Tgfa</italic>
###xml 622 626 610 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egfr</italic>
###xml 635 636 623 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 638 639 626 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 777 779 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
###xml 799 809 787 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
###xml 882 884 866 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F11">11</xref>
###xml 1330 1332 1310 1312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B81">81</xref>
###xml 411 415 <span type="species:ncbi:10090">mice</span>
###xml 440 444 <span type="species:ncbi:10090">mice</span>
###xml 587 592 <span type="species:ncbi:10090">mouse</span>
Our prior studies of in vitro SMG branching morphogenesis suggested that Eda/Edar signaling largely regulates ontogeny through the canonical NFkappaB pathway [14]. The present in vivo quantitative systems analyses indicate that this conclusion must be amended. The need to do so is inescapable because, for most NFkappaB-regulated genes, the observed time course of gene expression is nearly unchanged in Tabby mice as compared to wildtype mice (see Additional file 2), as is NFkappaB itself (Fig. 6). Importantly, a subset of genes is dramatically differentially expressed in the Tabby mouse (Edar, Fgf8, Shh, Egf, Tgfa, Egfr) (Figs. 5, 9), strongly suggesting the existence of an alternative Eda-mediated transcriptional pathway pivotal for SMG branching morphogenesis (Fig. 10). Experimental and in silico investigations have identified C/EBPalpha as a promising candidate (Fig. 11). Finally, it should be noted that upregulation of the Egf/Tgfalpha/Egfr pathway appears to mitigate the potentially severe abnormal phenotype predicted by the downregulation of Fgf8 and Shh. It has recently been suggested by Harris et al. that the buffering of the phenotypic outcome that is coincident with variant Eda signaling could be a common mechanism that permits viable and diverse phenotypes, including those we would consider normal [81]. Our results support this proposition.
###end p 75
###begin title 76
Methods
###end title 76
###begin p 77
###xml 42 45 42 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">W-J</sup>
###xml 50 53 50 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">W-J</sup>
###xml 267 271 267 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink">W-J/</sup>
###xml 276 278 276 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Ta</sup>
###xml 303 307 303 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink">W-J/</sup>
###xml 312 314 312 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Ta</sup>
###xml 530 534 530 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink">W-J </sup>
###xml 1103 1105 1096 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
###xml 646 650 <span type="species:ncbi:10090">mice</span>
Wildtype (WT) mice were either B6CBACaF1-AW-J/A (AW-J) or B10.A/SgSn obtained from Jackson Laboratories (Bar Harbor, ME) and bred as previously described (Jaskoll and Melnick, 1999; Jaskoll et al., 2003); plug day = day 0 of gestation. Tabby breeding pairs [B6CBACA AW-J/A-EdaTa/O/J (Ta/0) and B6CBACA AW-J/A-EdaTa/Y (Ta/Y)] were obtained from Jackson Laboratories and kept by breeding Ta/0 females to Ta/Y males. All embryos from the cross were either Ta/0 or Ta/Ta females and Ta/Y males and displayed the Tabby phenotype. The AW-J wildtype SMGs were used for all comparisons with Tabby glands. E13-19 Tabby and WT pregnant females and newborn mice were sacrificed, SMGs were dissected in cold phosphate-buffered saline (PBS) and glands were collected for morphological, immunolocalization or quantitative RT-PCR. For histological analysis, SMGs were fixed for 4 hrs in Carnoy's fixative at 4degreesC or overnight in 10% neutral buffered formalin at room temperature, embedded in low melting point paraplast, serially-sectioned at 8 mum and stained with hematoxylin and eosin as previously described [37]. For each embryonic day from gestation day 13 to 18, 5-15 WT and Tabby SMGs were analyzed.
###end p 77
###begin p 78
###xml 4 13 4 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 217 226 217 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
For in vitro culture experiments, B10A/SnSg mice were mated and pregnant females were sacrificed on day 14 of gestation (E14) as previously described [14,44] Embryonic SMGs were dissected under sterile conditions and in vitro experiments conducted as outlined below.
###end p 78
###begin p 79
All animal studies were conducted with the approval of the appropriate committees regulating animal research. An Animal Review Board and a Vivaria Advisory Committee review all applications to ensure ethical and humane treatment.
###end p 79
###begin title 80
Immunolocalization
###end title 80
###begin p 81
###xml 22 25 22 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">W-J</sup>
###xml 299 301 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 302 304 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 305 307 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B82">82</xref>
###xml 389 391 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B82">82</xref>
###xml 392 394 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B83">83</xref>
###xml 370 376 <span type="species:ncbi:9986">rabbit</span>
###xml 408 414 <span type="species:ncbi:9986">rabbit</span>
###xml 477 483 <span type="species:ncbi:9986">rabbit</span>
###xml 540 544 <span type="species:ncbi:9925">goat</span>
###xml 605 610 <span type="species:ncbi:10090">mouse</span>
E16-18 Tabby and WT (AW-J) glands were fixed for 4 hrs in Carnoy's fixative at 4degreesC or overnight in 10% neutral buffered formalin at room temperature, embedded in low melting point paraplast, serially sectioned at 8 mum and immunolocalization was conducted essentially as previously described [14,38,82] using the following affinity-purified antibodies: polyclonal rabbit anti Muc10 [82,83], polyclonal rabbit anti C/EBPalpha (sc-61; Santa Cruz Biotechnology), polyclonal rabbit anti Egfr (sc-03; Santa Cruz Biotechnology), polyclonal goat anti Egf (sc-1343; Santa Cruz Biotechnology) and monoclonal mouse anti Tgfalpha (sc-36; Santa Cruz Biotechnology). In selected experiments, nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI). For mucin protein localization, 3-4 WT and Tabby glands were analyzed for each embryonic day and 3-6 explants per treatment group were analyzed. For C/EBPalpha protein localization, 5 WT or Tabby glands were analyzed and 3-5 explants per treatment group were analyzed. For Egfr, Egf and Tgfalpha protein localization, 3-4 WT and Tabby glands were analyzed.
###end p 81
###begin title 82
Quantitative RT-PCR
###end title 82
###begin p 83
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 1862 1878 1828 1836 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-&#916;&#916;CTCT </sup>
For analysis of gene expression, quantitative RT-PCR was conducted as previously described [57]. WT and Tabby SMGs were pooled (WT-E15-17: 6-20 SMGs/sample; E18-NB: 2-4 SMGs/sample; Tabby-E16-17:15-20 SMGs/sample; E18-NB-4-6 SMGs/sample). For each embryonic day, in each of WT and Tabby, we performed quantitative RT-PCR on 9 or more independent samples. RNA was extracted and 1 mug RNA was reverse transcribed into first strand cDNA using ReactionReadytrade mark First Strand cDNA Synthesis Kit: C-01 for reverse transcription (Superarray Biosciences, Frederick, MD). The primer sets used were prevalidated to give single amplicons and purchased from Superarray Biosciences: Eda (#PPM40603E); Edar (#PPM32386A); Edaradd (PPM32128E); Fgf8 (#PPM02962C); Fgf10 (PPM0345A); Fgfr2 (PPM03706E); PI3k (PPM03469A); Akt (PPM03377A); ERK1 (PPM03575A); ERK2 (PPM03571A); Stat3 (PPM04643E); Egf (PPM03703C); Tgfa (PPM03051A); Egfr (PPM03714E); Ikbkb (PPM03198A); Nfkb1 (#PPM02930A); Nfkb2 (PPM03204A); Rela (#PPM04224E); Relb (#PPM03202C); Tnf (#PPM03113E); Traf2 (PPM03083E); Traf6 (PPM03082A); Il6 (#PPM03015A); p53 (#PPM02931A); Shh (#PPM04516B); cyclin D1 (PPM02903A); Cdk1 (PPM02907A); Casp3 (PPM02922E); Myc (PPM02924A); Ikka (PPM03197A); Ikbkap (PPM37360A); Cebpa (PPM04674A). Primers were used at concentration of 0.4 microM. The cycling parameters were 95degreesC, 15 min; 40 cycles of (95degreesC, 15 sec; 55degreesC, 30-40 sec and 72degreesC, 30 sec). Specificity of the reactions was determined by subsequent melting curve analysis. RT-PCRs of RNA (not reverse transcribed) were used as negative controls. GAPDH was used to control for equal cDNA inputs and the levels of PCR product were expressed as a function of GAPDH. The relative fold changes of gene expression between the gene of interest and GAPDH, or between the WT and Tabby, were calculated by the 2-DeltaDeltaCTCT method.
###end p 83
###begin title 84
Kinetic modeling and hypothesis testing
###end title 84
###begin title 85
Data mining
###end title 85
###begin p 86
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 990 991 990 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
Pathway and literature databases were mined for processes that interrelate a panel of pivotal genes in SMG development (Fig. 3; Table 1). We extracted relevant interactions and pathways from KEGG , OMIM , GeneCards , three models from the BioModels database , iHOP , and the scientific literature accessed through the PubMedCentral database . These data were manually curated and entered into the ProcessDB software . In some cases pathways were available in SBML  format and these were programmatically imported from the BioModels.net database into the ProcessDB database for re-use. The resulting mechanistic system diagram contains 138 states (a state is a molecule or a complex in a physical place) in 5 cellular locations (cytoplasm, nucleus, secretory pathway, plasma membrane and extracellular fluid), and 217 processes (transport, chemical reaction, or binding). It is too large to be displayed legibly on a journal page, but is provided as a scalable PDF file (see Additional file 1).
###end p 86
###begin title 87
Kinetic analysis and modeling
###end title 87
###begin p 88
###xml 63 64 63 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 444 449 <span type="species:ncbi:10090">mouse</span>
Experimental mRNA expression data on the genes listed in Table 1 were collected as described above and provided mRNA data on E15, E16, E17, E18, E19, and newborn (NB) for wild type (AW) embryos and on E16, E17, E18, E19, and NB for Tabby embryos whose glands are uniformly and significantly smaller. For each gene analyzed the data were normalized to the value obtained on E15 in the wild type animals. The defining characteristic of the Tabby mouse is an X-linked mutation that causes a major reduction in Eda mRNA. The underlying goal of the modeling work was to understand how this marked reduction in Eda propagates through the signal transduction and genetic networks to produce the observed temporal phenotypes for the measured panel of developmental genes.
###end p 88
###begin p 89
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B84">84</xref>
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B85">85</xref>
###xml 1577 1579 1577 1579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B86">86</xref>
A standard biophysical/bioengineering approach to kinetic analysis of a complex system containing many feedback and feedforward controls is to open the control loops by use of forcing functions [84,85]. We took advantage of the rich data set of measured mRNA time courses by using them as forcing functions for protein synthesis in the large-scale mechanistic kinetic model. This approach accelerates model development by propagating data-determined (and presumably correct) time courses through the network even before a consistent model has been obtained. Because Tabby glands are too small at ED15 to be practical for RT-PCR-based measurements, some method of extrapolation back from ED16 to ED15 was required for the Tabby forcing functions. Two methods were possible: 1) assume the value at ED15 is equal to the value at ED16 or 2) assume the slope determined by values at ED16 and ED17 is the same as the slope between ED15 and ED16. Choice 1 was seen as more conservative and was implemented. Rate law parameters and initial abundances were chosen throughout the protein network to propagate the main features of each mRNA developmental transient as faithfully as possible. Default rate laws, based on mass action kinetics were created automatically by ProcessDB for each process. This automatically produces saturation behavior for processes limited by the abundance of one or more reactants. Enzyme catalyzed processes and processes activated or inhibited by other states in the model were supplied with rate laws based on classical rapid equilibrium enzyme kinetics [86].
###end p 89
###begin p 90
###xml 258 263 <span type="species:ncbi:10090">mouse</span>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
Another useful modeling technique is, wherever feasible, to analyze multiple experiments simultaneously using the same mechanistic model. This could be implemented in the ProcessDB software, even though the present experiments are performed in two different mouse strains, by adopting the working hypothesis that WT and Tabby mice are identical except for the genetic defect in the Eda gene of the Tabby mutant. In other words, all differences between WT and Tabby developmental mRNA profiles are assumed to be secondary to the difference in Eda expression. In some cases fitting the WT and Tabby data sets required that states have different initial numerical values at ED15. This was allowed because the cytokine environment of the salivary gland in early embryonic development is undoubtedly different in the two strains. In all cases, however, parameter values and rate laws were taken as identical for the two strains. This is an extremely powerful modeling constraint. It does not mean, of course, that all unmeasured protein time courses are the same in the WT and Tabby models. Each is driven by the measured mRNA abundances so that known differences are propagated through common rate laws with the objective of testing the structure of the network - from cytokine production and secretion to receptor binding to activation of enzymes and transcription factors, to nuclear localization and activation or inhibition of cognate genes.
###end p 90
###begin p 91
###xml 719 720 719 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 738 739 738 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 757 758 757 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 776 777 776 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 795 796 795 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
Importantly, the use of mRNA forcing functions in no way guarantees that the full model will simultaneously fit the mRNA data that serve as forcing functions. This is because the control of nuclear transcription factors is, in general, multifactorial and mechanistically distant from synthesis of the proteins involved. Consequently, it was possible to test the mechanistic model's ability to account for the experimental data by searching for transcription and mRNA degradation parameters able to fit the WT and Tabby data simultaneously. The full mechanistic model file including all differential equations, ancillary algebraic equations, rate laws and parameters is included in Additional files (see Additional file 1; Additional file 2; Additional file 3; Additional file 4; Additional file 5).
###end p 91
###begin p 92
All differential equations and ancillary algebraic equations were formulated in ProcessDB and exported to the Berkeley Madonna  solver for numerical integration and parameter optimization using standard methods. Assembled pathway diagrams were treated as hypotheses and tested against the WT and Tabby experimental data.
###end p 92
###begin title 93
Transcription factor analysis
###end title 93
###begin p 94
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf8</italic>
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shh</italic>
###xml 34 37 34 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda</italic>
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tgfa</italic>
###xml 45 48 45 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egf</italic>
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egfr </italic>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
The mouse sequences of Fgf8, Shh, Eda, Tgfa, Egf, and Egfr were analyzed for the presence of putative TF DNA binding sites that are common to all 6 genes. We began with an unbiased search with AliBaba 2.1 , the most specific tool for predicting TF binding sites in an "anonymous" DNA sequence using the TRANSFEC database of TFs. The outcome was manually curated based upon mined pathway and literature databases (see Kinetic Modeling/Data mining above) and rank ordered. This analysis revealed SP1 and C/EBPalpha to be the most likely candidates. We then analyzed both candidates with greater stringency using MATCH 11.2 (proprietary; ) and P-MATCH 1.0 .
###end p 94
###begin p 95
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B87">87</xref>
###xml 389 395 389 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">match </italic>
###xml 525 531 525 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">match </italic>
###xml 657 663 657 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">match </italic>
###xml 834 842 834 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">matches </italic>
MATCH 11.2 is a weight matrix-based tool for searching putative TF binding sites in DNA sequences [87]. MATCH 11.2 uses the matrix library collected in TRANSFAC 12.1 (proprietary; ). Multiple sets of optimized matrix cut-off values are built into the tool to provide a variety of search modes of different stringency. The matrix similarity is a score (0-1) that describes the quality of a match between matrix and an arbitrary part of the input sequence. Analogously, the core similarity score (0-1) denotes the quality of a match between the core sequence of a matrix (the five most conserved positions within a matrix) and a part of the input sequence. A match has to contain the core sequence of a matrix, i.e. the core sequence has to match with a score higher than or equal to the core similarity cutoff. In addition, only those matches which score higher than or equal to the matrix similarity threshold appear in the output. Cut-offs were chosen to minimize false positive and false negative outcomes. Of the two candidate TFs revealed by AliBaba 2.1, only C/EBPalpha survived the more rigorous analysis.
###end p 95
###begin p 96
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B88">88</xref>
This outcome was confirmed using P-MATCH 1.0. P-MATCH combines weight-matrix and pattern matching analytical strategies, thus providing higher accuracy of recognition than either method alone [88]. P-MATCH 1.0 uses the library of mononucleotide weight matrices from TRANSFAC 6.0 (public) along with the site assignments associated with the matrices. Comparisons with MATCH, show that P-MATCH generally provides enhanced recognition accuracy vis-a-vis lower false negative errors (i.e. high sensitivity).
###end p 96
###begin title 97
###xml 23 31 23 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
EDA-A1 supplementation in vitro
###end title 97
###begin p 98
###xml 450 452 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1063 1065 1055 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1066 1068 1058 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1069 1071 1061 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1130 1131 1122 1123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1162 1164 1154 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B89">89</xref>
###xml 60 65 <span type="species:ncbi:9606">human</span>
To determine the optimal concentration of exogenous soluble human recombinant EDA-A1 that induces a significant increase in SMG branching and morphogenesis, we conducted a dose response study. This dose response study was conducted because the EDA-A1 recombinant set (EDA-A1 + enhancer molecule) (Alexis Biochemicals, Axxora, LLC, San Diego, CA) in the present set of experiments was different from the EDA-A1 peptide employed in our previous study [14]. A stock solution of 1 Phig/ml EDA-A1 (10 Phil EDA-A1 + 5 Phil Enhancer + 985 Phil BGJb containing 1% BSA) was made following the manufacturer's protocol and then diluted to 100, 250 and 500 ng/ml. Paired E14 SMG primordia were cultured for 2 days (E14 + 2) and 5-7 days in the presence or absence of 100, 250 and 500 ng/ml EDA-A1. For E14 + 2 explants, Spooner branch ratios (epithelial bud number on day 2/bud number on day 0) were calculated for each explant, comparisons made between right and left glands (treated and control) from each embryo and mean Spooner ratios determined as previously described [14,38,44]. The data were arcsin transformed and compared by paired t-test for all embryos studied [89]. Since branching morphogenesis is too complex to count in E14 explants cultured 5-7 days, the morphology of these explants were analyzed by routine hematoxylin and eosin histology; 4-6 explants per dose were analyzed for each day of culture. We determined the optimal dose to be 250 ng/ml EDA-A1 and this concentration was used in all subsequent experiments.
###end p 98
###begin title 99
SN50 inhibition of canonical NF6B nuclear translocation
###end title 99
###begin p 100
###xml 170 172 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 173 175 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 176 178 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B90">90</xref>
###xml 335 337 331 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#956;</italic>
###xml 500 502 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 503 505 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
The cell permeable peptide SN50 (Biomol Research, Plymouth Meeting, PA) has been shown to inhibit translocation of the canonical NFkappaB1/RelA pathway into the nucleus [32,56,90]. To determine the effect of SN50 on E14 SMG morphogenesis, paired E14 SMG primordia were cultured for 2 days or 5-7 days in the presence or absence of 100 mug/ml SN50. This concentration was previously shown in our laboratory to be the optimal inhibitor of NFkappaB1/RelA translocation and interrupts SMG morphogenesis [32,57]. The morphology of these explants was analyzed by routine hematoxylin and eosin histology; 4-6 explants per treatment group were analyzed.
###end p 100
###begin title 101
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
In vitro rescue experiments
###end title 101
###begin p 102
###xml 150 152 150 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#956;</italic>
###xml 188 190 187 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#956;</italic>
To determine if exogenous EDA-A1 rescues SN50-induced abnormal phenotypes, E14 SMGs were cultured for 7 days in the presence of 250 ng/ml EDA-A1, 100 mug/ml SN50 or 250 ng/ml EDA-A1 + 100 mug/ml SN50; control SMGs consisted of explants cultured in control medium. E14 + 7 explants were collected for histological analysis or quantitative RT-PCR as described above. The morphology of these explants was analyzed by routine hematoxylin and eosin histology; 20-25 explants per treatment group were analyzed. For RT-PCR, 9 independent samples per treatment of pooled glands (20-25 SMGs/sample/group) were analyzed.
###end p 102
###begin title 103
Probabilistic neural network (PNN) analysis
###end title 103
###begin p 104
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B91">91</xref>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B93">93</xref>
###xml 725 727 725 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B94">94</xref>
###xml 908 910 908 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B95">95</xref>
We used PNN analyses to determine the contribution of each individual gene to the discrimination between experimental groups with 100% sensitivity and specificity. As such, PNN analyses identify the relative importance (0-1, with 0 being of no relative importance and 1 being relatively most important) of specific gene expression changes that discriminate between phenotypes. It is the contextual change in expression, not the direction of change that is important in defining the molecular phenotype. The foundational algorithm we used is based upon the work of Specht and colleagues [91-93]. The proprietary software designed by Ward Systems Group (Frederick, MD) formulates Specht's procedure around a genetic algorithm [94]. A genetic algorithm is a computational method modeled on biologic evolutionary processes that can be used to find the optimum solution to a problem that may have many solutions [95]. These algorithms have been found to be very powerful in solving optimization problems that appear to be difficult or unsolvable by traditional methods. They use a minimum of information about the problem and they only require a quantitative estimation of the quality of a possible solution. This makes genetic algorithms easy to use and applicable to most optimization problems.
###end p 104
###begin title 105
Authors' contributions
###end title 105
###begin p 106
###xml 248 257 248 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
TJ and MM conceived and designed the study. MM was involved in and coordinated all experiments, as well as the modeling, and drafted the manuscript. TJ participated in RT-PCR analyses, analyzed the histological and localization data, conducted the in vitro experiments, and helped draft the manuscript. RP and SL participated in kinetic modeling and helped draft the manuscript. All authors read and approved the final manuscript.
###end p 106
###begin title 107
Supplementary Material
###end title 107
###begin title 108
Additional file 1
###end title 108
###begin p 109
###xml 0 30 0 30 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Mechanistic gene network model</bold>
Mechanistic gene network model. Diagram of the full mechanistic gene network model. Black arrows represent processes (chemical reactions, transport, or binding). Rectangles represent states. A state is a molecule or complex in a physiologic place. Places are represented by the background ivory or mauve bands of color and are labeled at the bottom of the diagram. Green and red dashed arrows represent, respectively, positive or negative regulation of processes by states. Processes with only starts or ends cross the boundary of the modeled system. This diagram and corresponding computational model were produced by ProcessDB software .
###end p 109
###begin p 110
Click here for file
###end p 110
###begin title 111
Additional file 2
###end title 111
###begin p 112
###xml 0 95 0 95 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Additional time course fits of the WT and Tabby experimental data by the full mechanistic model</bold>
###xml 215 216 215 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 218 219 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 221 222 221 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 247 251 247 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda </italic>
###xml 306 310 306 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eda </italic>
###xml 467 468 467 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 473 474 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 337 341 <span type="species:ncbi:10090">mice</span>
###xml 839 843 <span type="species:ncbi:10090">mice</span>
Additional time course fits of the WT and Tabby experimental data by the full mechanistic model. Time course fits of the WT and Tabby experimental data by the full mechanistic model that are not included in Figures 4, 5, 8 of the main text. Note, Eda is not included among the genes because differences in Eda expression in WT and Tabby mice are not attributable to transcriptional control. The vertical axis is the relative abundance of mRNA, as presented in Tables 1 and 2. The lines labeled "WT data" are the quantitative RT-PCR derived mRNA data in wildtype SMGs; the lines labeled "WT model" are model simulated expected mRNA expression for wildtype SMGs. The lines labeled "TA data" are the quantitative RT-PCR derived mRNA data in Tabby SMGs; the lines labeled "TA model" are model simulated expected mRNA expression for Tabby SMGs mice.
###end p 112
###begin p 113
Click here for file
###end p 113
###begin title 114
Additional file 3
###end title 114
###begin p 115
###xml 0 50 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Corresponding equations of the computational model</bold>
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
Corresponding equations of the computational model. Text file displaying the corresponding equations of the computational model shown in Additional file 1.
###end p 115
###begin p 116
Click here for file
###end p 116
###begin title 117
Additional file 4
###end title 117
###begin p 118
###xml 0 104 0 104 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A Berkeley Madonna model file modified slightly from the model file generated automatically by ProcessDB</bold>
A Berkeley Madonna model file modified slightly from the model file generated automatically by ProcessDB. A Berkeley Madonna  model file (MODE3680_20080326_final.mmd) containing all the equations and parameters for both WT and Tabby experiments, as well as the fits of the experimental data. This file can be run and examined using the free trial version of Berkeley Madonna.
###end p 118
###begin p 119
Click here for file
###end p 119
###begin title 120
Additional file 5
###end title 120
###begin p 121
###xml 0 75 0 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Berkeley Madonna variable names corresponding to those of the model diagram</bold>
###xml 192 193 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
Berkeley Madonna variable names corresponding to those of the model diagram. Table showing Berkeley Madonna variable names corresponding to those of the model diagram shown in Additional file 1.
###end p 121
###begin p 122
Click here for file
###end p 122
###begin title 123
Acknowledgements
###end title 123
###begin p 124
We would like to thank Pablo Bringas for photographic assistance. This research was supported by NIH grant RO1 DE014535 (TJ/MM).
###end p 124
###begin article-title 125
Do different branching epithelia use a conserved developmental mechanism?
###end article-title 125
###begin article-title 126
###xml 22 28 <span type="species:ncbi:10090">murine</span>
###xml 44 49 <span type="species:ncbi:9606">human</span>
Cloning of Tabby, the murine homolog of the human EDA gene: evidence for a membrane-associated protein with a short collagenous domain
###end article-title 126
###begin article-title 127
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
###xml 98 103 <span type="species:ncbi:10090">mouse</span>
###xml 108 113 <span type="species:ncbi:9606">human</span>
The Tabby phenotype is caused by mutation in a mouse homologue of the EDA gene that reveals novel mouse and human exons and encodes a protein (ectodysplasin-A) with collagenous domains
###end article-title 127
###begin article-title 128
Ectodysplasin is a collagenous trimeric type II membrane protein with a tumor necrosis factor-like domain and co-localizes with cytoskeletal structures at lateral and apical surfaces of cells
###end article-title 128
###begin article-title 129
Anhidrotic ectodermal dysplasia (EDA) protein expressed in MCF-7 cells associates with cell membrane and induces rounding
###end article-title 129
###begin article-title 130
Soluble TNF-alpha receptors are constitutively shed and downregulate adhesion molecule expression in malignant gliomas
###end article-title 130
###begin article-title 131
Ectodysplasin is released by proteolytic shedding and binds to the EDAR protein
###end article-title 131
###begin article-title 132
The Ectodysplasin and NFkappaB signalling pathways in odontogenesis
###end article-title 132
###begin article-title 133
The Edar subfamily in feather placode formation
###end article-title 133
###begin article-title 134
TNF superfamily in skin appendage development
###end article-title 134
###begin article-title 135
NF-kappaB transmits Eda A1/EdaR signalling to activate Shh and cyclin D1 expression, and controls post-initiation hair placode down growth
###end article-title 135
###begin article-title 136
###xml 36 41 <span type="species:ncbi:9606">human</span>
The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes
###end article-title 136
###begin article-title 137
Ectodysplasin receptor-mediated signaling is essential for embryonic submandibular salivary gland development
###end article-title 137
###begin article-title 138
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
Pleiotropic effect of Tabby gene on epidermal growth factor-containing cells of mouse submandibular gland
###end article-title 138
###begin article-title 139
Clinical aspects of X-linked hypohidrotic ectodermal dysplasia
###end article-title 139
###begin article-title 140
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
Genes and genotypes affecting the teeth of the mouse
###end article-title 140
###begin article-title 141
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
The glandular aspect of the tabby syndrome in the mouse
###end article-title 141
###begin article-title 142
Oligodontia is associated with extra-oral ectodermal symptoms and low whole salivary flow rates
###end article-title 142
###begin article-title 143
Salivary gland involvement in hypohidrotic ectodermal dysplasia
###end article-title 143
###begin article-title 144
###xml 27 34 <span type="species:ncbi:9606">persons</span>
Salivary gland function in persons with ectodermal dysplasias
###end article-title 144
###begin article-title 145
Ectodysplasin regulates the lymphotoxin-beta pathway for hair differentiation
###end article-title 145
###begin article-title 146
###xml 98 102 <span type="species:ncbi:10090">mice</span>
Candidate EDA targets revealed by expression profiling of primary keratinocytes from Tabby mutant mice
###end article-title 146
###begin article-title 147
Shadow enhancers as a source of evolutionary novelty
###end article-title 147
###begin article-title 148
Enhancing gene regulation
###end article-title 148
###begin article-title 149
Differentiation and gene regulation: toward a holistic understanding of animal development: intercellular communication and transcriptional regulation are two sides of the same coin
###end article-title 149
###begin article-title 150
Embryonic Salivary Gland Branching Morphogenesis
###end article-title 150
###begin article-title 151
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse submandibular gland morphogenesis: a paradigm for embryonic signal processing
###end article-title 151
###begin article-title 152
Salivary gland branching morphogenesis
###end article-title 152
###begin article-title 153
Salivary gland development
###end article-title 153
###begin article-title 154
The functional genomic response of developing embryonic submandibular glands to NF-kappa B inhibition
###end article-title 154
###begin article-title 155
From genotype to phenotype: systems biology meets natural variation
###end article-title 155
###begin article-title 156
The genetics of brain wiring: from molecule to mind
###end article-title 156
###begin article-title 157
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
Expression of epidermal growth factor receptor in fetal mouse submandibular gland detected by a biotinyltyramide-based catalyzed signal amplification method
###end article-title 157
###begin article-title 158
FGF10/FGFR2b signaling plays essential roles during in vivo embryonic submandibular salivary gland morphogenesis
###end article-title 158
###begin article-title 159
###xml 148 152 <span type="species:ncbi:10090">mice</span>
Submandibular gland morphogenesis: stage-specific expression of TGF-alpha/EGF, IGF, TGF-beta, TNF, and IL-6 signal transduction in normal embryonic mice and the phenotypic effects of TGF-beta2, TGF-beta3, and EGF-R null mutations
###end article-title 159
###begin article-title 160
FGF8 dose-dependent regulation of embryonic submandibular salivary gland morphogenesis
###end article-title 160
###begin article-title 161
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
Embryonic submandibular gland morphogenesis: stage-specific protein localization of FGFs, BMPs, Pax6 and Pax9 in normal mice and abnormal SMG phenotypes in FgfR2-IIIc(+/Delta), BMP7(-/-) and Pax6(-/-) mice
###end article-title 161
###begin article-title 162
###xml 82 87 <span type="species:ncbi:10090">mouse</span>
Epidermal growth factor system is a physiological regulator of development of the mouse fetal submandibular gland and regulates expression of the alpha6-integrin subunit
###end article-title 162
###begin article-title 163
###xml 10 15 <span type="species:ncbi:10090">mouse</span>
Embryonic mouse submandibular salivary gland morphogenesis and the TNF/TNF-R1 signal transduction pathway
###end article-title 163
###begin article-title 164
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
Interleukin-6 signaling and embryonic mouse submandibular salivary gland morphogenesis
###end article-title 164
###begin article-title 165
Modeling of signaling networks
###end article-title 165
###begin article-title 166
Sonic hedgehog signaling plays an essential role during embryonic salivary gland epithelial branching morphogenesis
###end article-title 166
###begin article-title 167
Regulatory gene networks and the properties of the development process
###end article-title 167
###begin article-title 168
A genomic regulatory network for development
###end article-title 168
###begin article-title 169
Global regulatory logic for specification of an embryonic cell lineage
###end article-title 169
###begin article-title 170
Kinetic modelling approaches to in vivo imaging
###end article-title 170
###begin article-title 171
A gene regulatory network subcircuit drives a dynamic pattern of gene expression
###end article-title 171
###begin article-title 172
Getting started in biological pathway construction and analysis
###end article-title 172
###begin article-title 173
Computational system biology
###end article-title 173
###begin article-title 174
Inferring genetic networks and identifying compound mode of action via expression profiling
###end article-title 174
###begin article-title 175
A new approach to decoding life: systems biology
###end article-title 175
###begin article-title 176
###xml 106 122 <span type="species:ncbi:562">Escherichia coli</span>
Insights into the relation between mRNA and protein expression patterns: II. Experimental observations in Escherichia coli
###end article-title 176
###begin article-title 177
Kinetic analysis of secretory protein traffic and characterization of golgi to plasma membrane transport intermediates in living cells
###end article-title 177
###begin article-title 178
Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence
###end article-title 178
###begin article-title 179
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
Cytomegalovirus-induced embryopathology: mouse submandibular salivary gland epithelial-mesenchymal ontogeny as a model
###end article-title 179
###begin article-title 180
Unraveling transcription regulatory networks by protein-DNA and protein-protein interaction mapping
###end article-title 180
###begin article-title 181
The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control
###end article-title 181
###begin article-title 182
Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction
###end article-title 182
###begin article-title 183
Prediction of potential C/EBP/NF-kappaB composite elements using matrix-based search methods
###end article-title 183
###begin article-title 184
Whole saliva in X-linked hypohidrotic ectodermal dysplasia
###end article-title 184
###begin article-title 185
Critical dynamics in genetic regulatory networks: examples from four kingdoms
###end article-title 185
###begin article-title 186
Gene expression dynamics in the macrophage exhibit criticality
###end article-title 186
###begin article-title 187
Perturbation avalanches and criticality in gene regulatory networks
###end article-title 187
###begin article-title 188
Why a simple model of genetic regulatory networks describes the distribution of avalanches in gene expression data
###end article-title 188
###begin article-title 189
Eukaryotic cells are dynamically ordered or critical but not chaotic
###end article-title 189
###begin article-title 190
Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses
###end article-title 190
###begin article-title 191
Requirement of NF-kappaB/Rel for the development of hair follicles and other epidermal appendices
###end article-title 191
###begin article-title 192
Epistasis: too often neglected in complex trait studies?
###end article-title 192
###begin article-title 193
Quantitative morphological signatures define local signaling networks regulating cell morphology
###end article-title 193
###begin article-title 194
A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis
###end article-title 194
###begin article-title 195
Attractors and democratic dynamics
###end article-title 195
###begin article-title 196
Integrating computational and biochemical studies to explore mechanisms in NF-kappaB signaling
###end article-title 196
###begin article-title 197
Edar and Troy signalling pathways act redundantly to regulate initiation of hair follicle development
###end article-title 197
###begin article-title 198
A systematic approach to detecting transcription factors in response to environmental stresses
###end article-title 198
###begin article-title 199
Cell-to-cell stochastic variation in gene expression is a complex genetic trait
###end article-title 199
###begin article-title 200
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish eda and edar mutants reveal conserved and ancestral roles of ectodysplasin signaling in vertebrates
###end article-title 200
###begin article-title 201
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
An alternatively spliced Muc10 glycoprotein ligand for putative L-selectin binding during mouse embryonic submandibular gland morphogenesis
###end article-title 201
###begin article-title 202
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse submandibular gland mucin: embryo-specific mRNA and protein species
###end article-title 202
###begin article-title 203
The formulation and testing of models
###end article-title 203
###begin article-title 204
MATCH: A tool for searching transcription factor binding sites in DNA sequences
###end article-title 204
###begin article-title 205
P-Match: transcription factor binding site search by combining patterns and weight matrices
###end article-title 205
###begin article-title 206
###xml 53 58 <span type="species:ncbi:9606">human</span>
Tumor necrosis factor-alpha-induced proliferation of human Mo7e leukemic cells occurs via activation of nuclear factor kappaB transcription factor
###end article-title 206
###begin article-title 207
Probabilistic neural network for classification, mapping, or associative memory
###end article-title 207
###begin article-title 208
Generalization accuracy of probabilistic neural networks captured with back-propagation networks
###end article-title 208

